Innovation in EU merger control: in need of a consistent framework

Innovation in EU merger control: in need of a consistent framework

Raphaël De Coninck
Antitrust & Competition | European competition

In Competition Law and Policy Debate, Raphaël De Coninck highlights the European Commission's recent interest in assessing the impact of pharmaceutical mergers on innovation. The article discusses the Commission’s approach and argues in favor of developing a consistent framework for assessing the impact of mergers on innovations. To read more, click the link below.

Download PDF